Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase II Study of S-1 + LV vs S-1 + LV + Oxaliplatin vs S-1 + Cisplatin in Advanced Gastric Cancer
jRCT2080221595Phase 2
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in gastric cancer (GC) comparing S-1 + leucovorin, S-1 + leucovorin + oxaliplatin and S-1 + cisplatin (3 arms).
02
Drugs
tegafurfolinic acidoxaliplatincisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT2080221595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221595.